COMPANION MEETINGS Society for Hematopathology   Sunday, February 27, 2011 — 1:30 p.m., CC 103 A/B   Reactive and Abnormal Lymphoid Proliferations Mimicking Malignant Lymphoma   Moderators: Cherie H. Dunphy, University of North Carolina, Chapel Hill, NC and Judith Ferry, Massachusetts General Hospital, Boston, MA   Disclosure: In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose. Click the button above to add this event to your Itinerary Planner... 1:30 Introduction: - Cherie H. Dunphy, University of North Carolina, Chapel Hill, NC 1:40 Viral-Associated Lymphoid Proliferations (To include discussion of EBV, CMV, HSV, and HHV6) Stefania Pittaluga, National Cancer Institute, Bethesda, MD 2:10 Immunodeficiency-Associated Lymphoid Proliferations (To include discussion of ALPS, HIV, and HHV8) - Amy Chadburn, Northwestern University, Chicago, IL 2:40 Therapy-Associated Lymphoid Proliferations (To include discussion of Methotrexate, Immunomodulator- Associated, Secondary ALL, Anti- Convulsant Hyperplasias) - Adam Bagg, Hospital of the University of Pennsylvania, Philadelphia, PA 3:40 Lymphoid Proliferations of Unknown Etiology (To include discussion of IgG4 Associated Sclerosing Lesions, Kikuchi, Kimura, and Coexistent Sinus Histiocytosis with Massive Lymphadenopathy and Langerhans Histiocytosis) - Dennis O'Malley, Clarient Inc., Aliso Viejo, CA 4:10 Early Lymphoid Lesions (To include discussion of In-Situ Mantle Cell Lymphoma, In-Situ Follicular Lymphoma, Monoclonal Light Chain Lesions in pediatric patients, Monoclonal B-cell lymphocytosis) - Elias Campo, University of Barcelona, Spain 4:40 Panel Discussion - All Presenters and Moderators with Audience Participation The Executive Committee of the Society for Hematopathology determines the subjects for symposia based on input from the membership of the Society. The topic was chosen from a survey of members conducted by the Society for Hematopathology which identified reactive and abnormal lymphoid proliferations as a topic that they were highly interested in for a future symposium. Rapid advances in understanding the ancillary molecular studies in reactive and atypical lymphoid proliferations have occurred in recent years, and aid in understanding and diagnosing these lymphoid proliferations. The purpose of the program will be to provide members of the Society and others with an interest in hematopathology an in-depth discussion of recent advances in the molecular pathogenesis and understanding of reactive and abnormal lymphoid proliferations.